IQVIA Holdings Inc

IQV

New York Stock Exchange. Currency in USD

189.43 -1.19 ( -0.62% )

Real time prices: September 23

Market Cap.
35.33B
Beta (5Y monthly)
1.35
Price/Earnings
21.72
EPS (TTM)
9.63
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.24M
1y Target Est.
300.29
Day's Range
186.24
-
191.21
52 Week's Range
186.24
-
285.61

Historical Summary

Performance
EPS growth
Share Buybacks

About IQVIA Holdings Inc

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.iqvia.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
191.04M
Employees
83000
Address
4820 Emperor boulevard, Durham, NC, United States, 27703
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Latest news

Paychex (PAYX) to Report Q1 Earnings: What's in the Cards?
Paychex (PAYX) to Report Q1 Earnings: What's in the Cards?

Paychex's (PAYX) first-quarter fiscal 2023 earnings and revenues are likely to have surged from the...
By Zacks Investment Research - 1 day ago

Accenture (ACN) Beats on Q4 Earnings, Hikes 15% Dividend
Accenture (ACN) Beats on Q4 Earnings, Hikes 15% Dividend

Accenture's (ACN) fourth-quarter fiscal 2022 earnings and revenues surge year over year.
By Zacks Investment Research - 2 days ago

Accenture (ACN) Beats Q4 Earnings Estimates
Accenture (ACN) Beats Q4 Earnings Estimates

Accenture (ACN) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter...
By Zacks Investment Research - 2 days ago

What's in the Offing for Accenture (ACN) in Q4 Earnings?
What's in the Offing for Accenture (ACN) in Q4 Earnings?

Accentures' (ACN) fourth-quarter fiscal 2022 earnings are expected to have benefited from higher revenues and...
By Zacks Investment Research - 4 days ago

FactSet (FDS) to Report Q4 Earnings: What's in the Offing?
FactSet (FDS) to Report Q4 Earnings: What's in the Offing?

FactSet's (FDS) fourth-quarter fiscal 2022 earnings and revenues are expected to have increased year over...
By Zacks Investment Research - 5 days ago

Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock
Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock

IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
By Zacks Investment Research - 1 week ago

Expert Ratings for IQVIA Hldgs
Expert Ratings for IQVIA Hldgs

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: Bullish...
By Benzinga - 1 week ago

DocuSign's (DOCU) Q2 Earnings Beat Estimates, Stock Up 10.5%
DocuSign's (DOCU) Q2 Earnings Beat Estimates, Stock Up 10.5%

DocuSign's (DOCU) second-quarter fiscal 2023 earnings decline but revenues increase year over year.
By Zacks Investment Research - 1 week ago